Search Results - "Melms, Arthur"
-
1
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
Published in Journal of Neurology (01-08-2016)“…Myasthenia gravis (MG) is an autoimmune antibody-mediated disorder of neuromuscular synaptic transmission. The clinical hallmark of MG consists of fluctuating…”
Get full text
Journal Article Book Review -
2
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Published in Autoimmunity reviews (01-07-2013)“…Abstract The thymus plays distinct roles in the pathogenesis of the different Myasthenia gravis (MG) subtypes. Inflammatory, neoplastic and age-related…”
Get full text
Journal Article -
3
Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis
Published in Journal of neurology (01-03-2012)“…Myasthenia gravis (MG) is an autoimmune disorder characterized by a defect in synaptic transmission at the neuromuscular junction causing fluctuating muscle…”
Get full text
Journal Article -
4
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System
Published in The Journal of immunology (1950) (15-02-2016)“…Monocytes represent a heterogeneous population of primary immune effector cells. At least three different subsets can be distinguished based on expression of…”
Get full text
Journal Article -
5
Exploring the MHC-peptide matrix of central tolerance in the human thymus
Published in Nature communications (19-06-2013)“…Ever since it was discovered that central tolerance to self is imposed on developing T cells in the thymus through their interaction with self-peptide major…”
Get full text
Journal Article -
6
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics
Published in Neurobiology of disease (01-04-2009)“…Abstract About one fourth of Lewy body disease (LBD) patients show cortical β-amyloid load, basically a hallmark of Alzheimer disease (AD). Using [11…”
Get full text
Journal Article -
7
Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?
Published in PloS one (08-03-2017)“…Fingolimod is an oral sphingosine-1-phosphate-receptor modulator which reduces the recirculation of immune cells and may also directly target glial cells. Here…”
Get full text
Journal Article -
8
Guideline for the management of myasthenic syndromes
Published in Therapeutic Advances in Neurological Disorders (01-01-2023)“…Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiologically heterogeneous group of…”
Get full text
Book Review Journal Article -
9
Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients
Published in The Journal of immunology (1950) (15-07-2009)“…FOXP3-expressing naturally occurring CD4(+)CD25(high) T regulatory cells (Treg) are relevant in the control of autoimmunity, and a defect in this cell…”
Get full text
Journal Article -
10
Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model
Published in Neurobiology of disease (01-03-2007)“…Abstract In the pathogenesis of Parkinson’s disease (PD), oxidative and nitrosative stress, apoptosis, mitochondrial dysfunction, and excitotoxicity are…”
Get full text
Journal Article -
11
Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations
Published in Molecular medicine (Cambridge, Mass.) (01-01-2015)“…To investigate the genetics of late-onset myasthenia gravis (LOMG), we conducted a genome-wide association study imputation of>6 million single nucleotide…”
Get full text
Journal Article -
12
Elevated Plasma Levels of Neuropeptide Proenkephalin A Predict Mortality and Functional Outcome in Ischemic Stroke
Published in Journal of the American College of Cardiology (24-07-2012)“…Objectives The purpose of this study was to investigate neuropeptides in patients presenting with symptoms of acute cerebrovascular disease. Background The…”
Get full text
Journal Article -
13
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells
Published in Journal of neuroinflammation (22-09-2013)“…Neural stem/progenitor cells (NSPCs) have the ability to migrate into the central nervous system (CNS) to replace damaged cells. In inflammatory CNS disease,…”
Get full text
Journal Article -
14
New poteintial serum biomarkers in multiple sclerosis identified by proteomic strategies
Published in Current medicinal chemistry (31-03-2014)“…Proteome analysis of body fluids is a powerful tool to identify biomarkers of neurological disorders. Multiple sclerosis (MScl) is a chronic disabling disorder…”
Get more information
Journal Article -
15
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia
Published in PloS one (25-10-2012)“…Parkinson's disease (PD) without (non-demented, PDND) and with dementia (PDD), and dementia with Lewy bodies (DLB) are subsumed under the umbrella term Lewy…”
Get full text
Journal Article -
16
Isolation of myeloid dendritic cells and epithelial cells from human thymus
Published in Journal of visualized experiments (19-09-2013)“…In this protocol we provide a method to isolate dendritic cells (DC) and epithelial cells (TEC) from the human thymus. DC and TEC are the major antigen…”
Get full text
Journal Article -
17
Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis
Published in The Journal of clinical investigation (01-08-2003)“…Stepwise degradation of the invariant chain (Ii) is required for the binding of antigenic peptides to MHC class II molecules. Cathepsin (Cat) L in the murine…”
Get full text
Journal Article -
18
No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases
Published in Neurobiology of disease (01-08-2009)“…Abstract Butyrylcholinesterase (BChE) genotypes and protein (BuChE) activity, especially in combination with Apolipoprotein E4 (ApoE4), have been investigated…”
Get full text
Journal Article -
19
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Published in Neurology (19-01-2021)“…OBJECTIVETo update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature…”
Get full text
Journal Article -
20
International consensus guidance for management of myasthenia gravis: Executive summary
Published in Neurology (26-07-2016)“…OBJECTIVE:To develop formal consensus-based guidance for the management of myasthenia gravis (MG). METHODS:In October 2013, the Myasthenia Gravis Foundation of…”
Get full text
Journal Article